Impact of Non-dialysis Chronic Kidney Disease on Survival in Patients with Septic Shock
Overview
Authors
Affiliations
Background: Chronic kidney disease (CKD) is known to expose the patient to a high risk of death due to cardiovascular and infective causes. In parallel, septic shock is a major challenge for cardiovascular and immune system. Therefore we tried to determine whether non-dialysis CKD, defined as a baseline estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2, for three months prior to the onset of septic shock is an independent risk factor for death.
Methods: All patients treated in a teaching hospital medical ICU for septic shock between January 2007 and December 2009 were retrospectively analyzed. Patients in whom baseline eGFR could not be determined (n=14) or patients treated by chronic dialysis (n=21) or kidney transplantation (n=14) were excluded. A total of 163 patients were included. The population was divided according to baseline eGFR ≥ 60 ml/min/1.73 m2 (non-CKD group, n=107) and < 60 ml/min/1.73 m2 (CKD group, n=56). Twenty-eight-day and 1-year survival curves were plotted. Prognostic factors were determined using Cox proportional hazards models.
Results: Baseline eGFR was significantly higher in the non-CKD group than in the CKD group (81 (67-108) vs. 36 (28-44) ml/min/1.73 m2, respectively; p=0.001). Age, SAPS II, serum creatinine on admission and the number of patients with a history of diabetes, hypertension, heart failure, peripheral artery disease, coronary artery disease and statin medication were significantly higher in the CKD group than in the non-CKD group. The mortality rate was lower in the non-CKD group than in the CKD group after 28 days (50% vs. 70%, respectively; p=0.03) and 1 year (64% vs. 82%, respectively; p=0.03). On multivariate analysis, the dichotomous variable CKD (eGFR < 60 ml/min/1.73 m2) remained significantly associated with the 28-day and 1-year mortality.
Conclusions: Non-dialysis CKD appears to be an independent risk factor for death after septic shock.
Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications.
Anders H, Li Q, Steiger S Clin Kidney J. 2023; 16(6):928-938.
PMID: 37261000 PMC: 10229286. DOI: 10.1093/ckj/sfad006.
Park H, Lee J, Oh D, Park M, Lim C, Lee S Sci Rep. 2023; 13(1):6351.
PMID: 37072424 PMC: 10113181. DOI: 10.1038/s41598-023-33227-7.
Cho J, Kim S, Woo C, Kwon S, Choe K, Kim E Int J Mol Sci. 2023; 24(6).
PMID: 36982713 PMC: 10053314. DOI: 10.3390/ijms24065641.
Kattouf N, Assaf M, Haidar S, Bachir R, El Sayed M, BouChebl R Emerg Med Int. 2023; 2022:6386078.
PMID: 36619805 PMC: 9822740. DOI: 10.1155/2022/6386078.
Liu X, Zhang B, Cheng Y, Tao W, Yuan C, Wei Z World J Gastrointest Oncol. 2022; 14(6):1199-1209.
PMID: 35949210 PMC: 9244980. DOI: 10.4251/wjgo.v14.i6.1199.